Year 2000 |
Lynk Biotechnologies was spun off from National University of Singapore
(NUS) with ~S$1 million investment from angel investors. |
Year 2002 |
Launch of Biolyn Hair Serum. |
Year 2003 |
Biolyn Hair Serum technology sold to Lo Hong Ka (HK). |
Year 2003 |
Launch of TGC (Transdermal Glucosamine Cream) (for joint health). |
Year 2004 |
Launch of TGC Plus Capsaicin. |
Year 2004 |
Patent on "Novel Ligands And Methods For Preparing The Same" granted in
Singapore. |
Year 2004 |
Incorporation of MediLynk Pte Ltd as a subsidiary with S$2.5 million
investment from Whiterock Investment. |
Year 2005 |
Launch of ANDRO Cream For Men (for male vitality) and Oestro Cream
(for bust firming). |
Year 2005 |
Successful completion of Phase I Clinical Trial for TGC at the Singapore
Changi General Hospital. |
Year 2005 |
Investment of S$6 million into Lynk by a group of private investors led
by Mr. Lim Kim Hai. |
Year 2005 |
Incorporation of DynaLynk Pharma Pte Ltd, a joint venture with Dynavest Pte Ltd to expand manufacturing capability. |
Year 2006 |
Development of trans-epidermal T-MAX cream (to relieve pain and itch). |
Year 2007 |
Successful completion of Phase II Clinical Trial For TGC in Indonesia
(at the Faculty of Medicine - University of Indonesia, and the Cipto
Mangunkusumo Central Hospital, Jakarta, Indonesia Hospital). |
Year 2008 |
DynaLynk Pharma Pte Ltd attained pharmaceutical GMP (Good Manufacturing
Practice) certification accredited by the Health Sciences Authority of
Singapore (HSA).
|
Year 2010 |
Launch of JUMPSTART Instant Energy Cream. |
Year 2011 |
Launch of TummyTuck Slimming Cream. |